Discover the critical bioanalytical factors that influence radiopharmaceutical drug development, from assay design to ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Von Willebrand disease (VWD) is the most common bleeding disorder, with a reported prevalence of approximately 1 in 1000 persons caused by inherited defects in the concentration, structure, or ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

CEO Jasbir Seehra outlined the company’s development priorities and partnership plans during a presentation at Oppenheimer’s ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI);("Scinai" or the "Company"), today announced the execution of a Second ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...

Creative BioMart, a leading provider of biotechnological services specializing in protein research products and services, has officially launched its detergent micelle platform. This specialized ...

The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...

Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...

Interested parties can access live audio webcasts of these presentations via the Investor Relations section of the company’s website at www.shattucklabs.com. Replay webcasts will be available for ...